Authorized Generics for Memary, Celecox among Approval List towards June Listing

February 18, 2020
Authorized generic (AG) versions of Daiichi Sankyo’s Alzheimer’s drug Memary (memantine) and Astellas Pharma’s analgesic antiphlogistic Celecox (celecoxib) were among the latest generic approval roster unveiled on February 17 towards price listing in June. Among 14 drugs facing copycat competition...read more